James Heyes
Impact in
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Lipid Membrane Structure and Behavior
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 14
- Advanced biosensing and bioanalysis techniques 9
- RNA Research and Splicing 1
-
- Immunotherapy and Immune Responses 3
- Phagocytosis and Immune Regulation 1
- Co-authors
- Ian MacLachlan (4 shared papers)Peter Lutwyche (2 shared papers)Lorne Palmer (7 shared papers)Eleni Samaridou (2 shared papers)K. Helen Bremner (1 shared paper)Caroline J. Springer (3 shared papers)Dan Niculescu‐Duvaz (2 shared papers)Kieu Lam (8 shared papers)
- Journals
- Molecular Therapy (4 papers)Advanced Materials (2 papers)Journal of Controlled Release (2 papers)Nature Communications (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesCanadaThailand
In The Last Decade
James Heyes
16 papers receiving 1.9k citations
James Heyes's Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 1.7k
- Biomaterials 241
- Immunology 299
- Genetics 359
- Infectious Diseases 216
Countries citing papers authored by James Heyes
This map shows the geographic impact of James Heyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Heyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Heyes more than expected).
Fields of papers citing papers by James Heyes
This network shows the impact of papers produced by James Heyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Heyes. The network helps show where James Heyes may publish in the future.
Co-authors
The 25 scholars most cited alongside James Heyes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 475 | |
| 2 | Lipid nanoparticles for nucleic acid delivery: Current perspectives Hit paper breakdown → | 2020 | 464 |
| 3 | Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine Hit paper breakdown → | 2022 | 224 |
| 4 | 2005 | 173 | |
| 5 | 2001 | 134 | |
| 6 | 2003 | 128 | |
| 7 | 2006 | 102 | |
| 8 | 2023 | 82 | |
| 9 | 2023 | 74 | |
| 10 | 2007 | 71 | |
| 11 | Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer. | 1999 | 17 |
| 12 | 2024 | 16 | |
| 13 | 2022 | 13 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 6 | |
| 16 | 2025 | 3 | |
| 17 | 2026 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2026 | 0 |
About James Heyes
James Heyes is a scholar working on Molecular Biology, Immunology, Genetics, Infectious Diseases and Animal Science and Zoology, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Advanced biosensing and bioanalysis techniques (9 papers), Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (3 papers), Cancer Research and Treatments (3 papers), Animal Virus Infections Studies (3 papers), Phagocytosis and Immune Regulation (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Molecular Biology (1.7k citations), Biomaterials (241 citations), Immunology (299 citations), Genetics (359 citations) and Infectious Diseases (216 citations). James Heyes has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Ian MacLachlan, Peter Lutwyche, Lorne Palmer, Eleni Samaridou, K. Helen Bremner, Caroline J. Springer, Dan Niculescu‐Duvaz, Kieu Lam, Robert G. Cooper and P.R. Cullis. Their work appears in journals such as Molecular Therapy, Advanced Materials, Journal of Controlled Release, Nature Communications and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.